Cancer drugs tested for use against zoonotic bioweapons

04/7/2013 | FoxNews.com

Zoonotic illnesses such as monkeypox and Ebola are potential bioweapons, and the Defense Threat Reduction Agency is funding research into how two cancer medications -- Gleevec and Tasigna -- could serve as a defense against such attacks. The idea is that the drugs could slow an infection, allowing the immune system to mount an effective response. Scientists hope to develop a general defense against a variety of potential bioweapons because producing a separate drug for use against each agent is not practical.

View Full Article in:

FoxNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC